These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 31813254)
1. TAK1 deficiency attenuates cisplatin-induced acute kidney injury. Zhou J; An C; Jin X; Hu Z; Safirstein RL; Wang Y Am J Physiol Renal Physiol; 2020 Jan; 318(1):F209-F215. PubMed ID: 31813254 [TBL] [Abstract][Full Text] [Related]
2. TAK1 mediates excessive autophagy via p38 and ERK in cisplatin-induced acute kidney injury. Zhou J; Fan Y; Zhong J; Huang Z; Huang T; Lin S; Chen H J Cell Mol Med; 2018 May; 22(5):2908-2921. PubMed ID: 29504713 [TBL] [Abstract][Full Text] [Related]
3. PARVB deficiency alleviates cisplatin-induced tubular injury by inhibiting TAK1 signaling. Yang A; Ding Y; Guo C; Liu C; Xiong Z; Quan M; Bai P; Cai R; Li B; Li G; Deng Y; Wu C; Sun Y Cell Mol Life Sci; 2024 Sep; 81(1):385. PubMed ID: 39235496 [TBL] [Abstract][Full Text] [Related]
4. CXCL16 regulates cisplatin-induced acute kidney injury. Liang H; Zhang Z; He L; Wang Y Oncotarget; 2016 May; 7(22):31652-62. PubMed ID: 27191747 [TBL] [Abstract][Full Text] [Related]
5. TAK1 mediates apoptosis via p38 involve in ischemia-induced renal fibrosis. Zhou J; Zhong J; Huang Z; Liao M; Lin S; Chen J; Chen H Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1016-1025. PubMed ID: 29661023 [TBL] [Abstract][Full Text] [Related]
6. Activation of GSDMD contributes to acute kidney injury induced by cisplatin. Li Y; Xia W; Wu M; Yin J; Wang Q; Li S; Zhang A; Huang S; Zhang Y; Jia Z Am J Physiol Renal Physiol; 2020 Jan; 318(1):F96-F106. PubMed ID: 31682173 [TBL] [Abstract][Full Text] [Related]
7. Conditional knockout of TGF-βRII /Smad2 signals protects against acute renal injury by alleviating cell necroptosis, apoptosis and inflammation. Yang Q; Ren GL; Wei B; Jin J; Huang XR; Shao W; Li J; Meng XM; Lan HY Theranostics; 2019; 9(26):8277-8293. PubMed ID: 31754396 [No Abstract] [Full Text] [Related]
8. SIRT2 is involved in cisplatin-induced acute kidney injury through regulation of mitogen-activated protein kinase phosphatase-1. Jung YJ; Park W; Kang KP; Kim W Nephrol Dial Transplant; 2020 Jul; 35(7):1145-1156. PubMed ID: 32240312 [TBL] [Abstract][Full Text] [Related]
9. Dual-specificity phosphatase 26 protects against kidney injury caused by ischaemia-reperfusion through restraint of TAK1-JNK/p38-mediated apoptosis and inflammation of renal tubular epithelial cells. Xiang H; Li Z; Li Y; Zheng J; Dou M; Xue W; Wu X Toxicol Appl Pharmacol; 2024 Jun; 487():116954. PubMed ID: 38705402 [TBL] [Abstract][Full Text] [Related]
10. CD4 T cell knockout does not protect against kidney injury and worsens cancer. Ravichandran K; Wang Q; Ozkok A; Jani A; Li H; He Z; Ljubanovic D; Weiser-Evans MC; Nemenoff RA; Edelstein CL J Mol Med (Berl); 2016 Apr; 94(4):443-55. PubMed ID: 26620676 [TBL] [Abstract][Full Text] [Related]
11. Chicken ovalbumin upstream promoter-transcription factor II protects against cisplatin-induced acute kidney injury. Ishii S; Yamada M; Koibuchi N Endocr J; 2020 Mar; 67(3):283-293. PubMed ID: 31801919 [TBL] [Abstract][Full Text] [Related]
12. TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney. Ma FY; Tesch GH; Ozols E; Xie M; Schneider MD; Nikolic-Paterson DJ Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1410-21. PubMed ID: 21367917 [TBL] [Abstract][Full Text] [Related]
13. AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway. Tsogbadrakh B; Ryu H; Ju KD; Lee J; Yun S; Yu KS; Kim HJ; Ahn C; Oh KH Biochem Biophys Res Commun; 2019 Feb; 509(3):680-686. PubMed ID: 30616891 [TBL] [Abstract][Full Text] [Related]
14. Regulator of calcineurin 1 deletion attenuates mitochondrial dysfunction and apoptosis in acute kidney injury through JNK/Mff signaling pathway. Xiao JJ; Liu Q; Li Y; Peng FF; Wang S; Zhang Z; Liu H; Yu H; Tao S; Zhang BF Cell Death Dis; 2022 Sep; 13(9):774. PubMed ID: 36071051 [TBL] [Abstract][Full Text] [Related]
15. DNA methylation protects against cisplatin-induced kidney injury by regulating specific genes, including interferon regulatory factor 8. Guo C; Pei L; Xiao X; Wei Q; Chen JK; Ding HF; Huang S; Fan G; Shi H; Dong Z Kidney Int; 2017 Nov; 92(5):1194-1205. PubMed ID: 28709638 [TBL] [Abstract][Full Text] [Related]
16. IL-33 deficiency slows cancer growth but does not protect against cisplatin-induced AKI in mice with cancer. Ravichandran K; Holditch S; Brown CN; Wang Q; Ozkok A; Weiser-Evans MC; Nemenoff R; Miyazaki M; Thiessen-Philbrook H; Parikh CR; Ljubanovic D; Edelstein CL Am J Physiol Renal Physiol; 2018 Mar; 314(3):F356-F366. PubMed ID: 29070568 [TBL] [Abstract][Full Text] [Related]
17. A Role for Tubular Necroptosis in Cisplatin-Induced AKI. Xu Y; Ma H; Shao J; Wu J; Zhou L; Zhang Z; Wang Y; Huang Z; Ren J; Liu S; Chen X; Han J J Am Soc Nephrol; 2015 Nov; 26(11):2647-58. PubMed ID: 25788533 [TBL] [Abstract][Full Text] [Related]
18. Restoration of E-cadherin by PPBICA protects against cisplatin-induced acute kidney injury by attenuating inflammation and programmed cell death. Gao L; Liu MM; Zang HM; Ma QY; Yang Q; Jiang L; Ren GL; Li HD; Wu WF; Wang JN; Wei B; Liu XQ; Jiang C; Huang C; Li J; Meng XM Lab Invest; 2018 Jul; 98(7):911-923. PubMed ID: 29581579 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological and genetic inhibition of fatty acid-binding protein 4 alleviated cisplatin-induced acute kidney injury. Tan Z; Guo F; Huang Z; Xia Z; Liu J; Tao S; Li L; Feng Y; Du X; Ma L; Fu P J Cell Mol Med; 2019 Sep; 23(9):6260-6270. PubMed ID: 31286669 [TBL] [Abstract][Full Text] [Related]
20. The water-soluble triptolide derivative PG490-88 protects against cisplatin-induced acute kidney injury. Kim HJ; Ravichandran K; Ozkok A; Wang Q; He Z; Jani A; Ljubanovic D; Douglas IS; Edelstein CL J Pharmacol Exp Ther; 2014 Jun; 349(3):518-25. PubMed ID: 24727856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]